Fetal safety of macrolides.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3697347)

Published in Antimicrob Agents Chemother on May 06, 2013

Authors

Anat Bahat Dinur1, Gideon Koren, Ilan Matok, Arnon Wiznitzer, Elia Uziel, Rafael Gorodischer, Amalia Levy

Author Affiliations

1: Department of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Articles cited by this

Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2003) 3.75

Drugs in pregnancy. N Engl J Med (1998) 3.14

The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res A Clin Mol Teratol (2003) 1.58

Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol (2003) 1.30

The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview. Curr Pharm Des (2004) 1.25

Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med (2002) 1.21

Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol (2003) 1.19

The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG (2000) 1.17

Azithromycin and erythromycin in the treatment of cervical chlamydial infection during pregnancy. Obstet Gynecol (1994) 1.17

Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin. Obstet Gynecol (1998) 1.12

Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth (2006) 1.08

The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med (2009) 1.07

A prospective controlled multicentre study of clarithromycin in pregnancy. Am J Perinatol (1998) 0.99

Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study. Eur J Obstet Gynecol Reprod Biol (2008) 0.96

Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. J Matern Fetal Med (1999) 0.91

Bias toward the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists. J Clin Pharmacol (2011) 0.89

The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study. Drug Saf (2012) 0.87

Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway. Br J Clin Pharmacol (2012) 0.86

Antibiotic use and intussusception in early childhood. J Antimicrob Chemother (2009) 0.85

Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations. Pharmacoepidemiol Drug Saf (2000) 0.84

Fetal outcome following roxithromycin exposure in early pregnancy. J Matern Fetal Neonatal Med (2006) 0.82

The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental? Drug Saf (2002) 0.80

Articles by these authors

Prevalence of depression during pregnancy: systematic review. Obstet Gynecol (2004) 5.42

Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry (2013) 3.71

Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol (2013) 3.68

Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. J Pediatr (2011) 2.86

Variables associated with medication errors in pediatric emergency medicine. Pediatrics (2002) 2.86

Gestational diabetes: the need for a common ground. Lancet (2009) 2.80

Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can (2007) 2.64

Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther (2002) 2.53

Perinatal risks of untreated depression during pregnancy. Can J Psychiatry (2004) 2.50

Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology (2014) 2.41

Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med (2002) 2.32

Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol (2012) 2.23

Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry (2008) 2.22

The Association Between Hospital Readmission and Pulmonologist Follow-up Visits in Patients With COPD. Chest (2015) 2.05

The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG (2004) 2.04

The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol (2009) 2.03

FDA pregnancy risk categories and the CPS: do they help or are they a hindrance? Can Fam Physician (2010) 2.02

Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry (2008) 2.01

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry (2005) 2.00

Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ (2005) 1.99

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther (2007) 1.98

Role of fetal length in the prediction of fetal weight. J Ultrasound Med (2012) 1.97

Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome. Nat Genet (2002) 1.96

Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest (2008) 1.93

Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther (2003) 1.91

Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit (2003) 1.91

Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin Invest Med (2007) 1.91

Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit (2009) 1.89

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry (2012) 1.88

Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician (2007) 1.83

Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril (2006) 1.80

Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells (2008) 1.78

Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions. Psychoneuroendocrinology (2011) 1.78

Child neurodevelopmental outcome and maternal occupational exposure to solvents. Arch Pediatr Adolesc Med (2004) 1.77

Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can (2009) 1.76

Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet (2010) 1.73

Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol (2009) 1.72

Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. Reprod Toxicol (2007) 1.70

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry (2002) 1.68

Historical perspective: the original description of fetal alcohol spectrum disorder in France, 1967. Ther Drug Monit (2003) 1.68

The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.67

The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.66

Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry (2013) 1.65

Pregnancy outcome following non-obstetric surgical intervention. Am J Surg (2005) 1.65

Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. Am J Surg (2009) 1.65

More codeine fatalities after tonsillectomy in North American children. Pediatrics (2012) 1.63

Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology (2005) 1.62

Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm (2012) 1.62

Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health (Larchmt) (2013) 1.60

Pregnancy and isotretinoin therapy. CMAJ (2013) 1.60

Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf (2002) 1.58

Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med (2009) 1.57

Discrepancies between ordered and delivered concentrations of opiate infusions in critical care. Crit Care Med (2003) 1.55

Hair mercury levels of women of reproductive age in Ontario, Canada: implications to fetal safety and fish consumption. J Pediatr (2010) 1.52

Breast-feeding during maternal use of azathioprine. Ann Pharmacother (2006) 1.52

Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm (2013) 1.50

A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145]. BMC Pregnancy Childbirth (2006) 1.50

Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother (2003) 1.48

Perineal massage during pregnancy: a prospective controlled trial. Isr Med Assoc J (2008) 1.47

Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med (2002) 1.44

Hair methylmercury: a new indication for therapeutic monitoring. Ther Drug Monit (2010) 1.44

Safety of the newer class of opioid antagonists in pregnancy. Can Fam Physician (2014) 1.43

Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila) (2010) 1.43

Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol (2011) 1.43

Evaluation of drug formularies for pediatric intensive care. Pediatr Crit Care Med (2011) 1.42

Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. AJR Am J Roentgenol (2004) 1.42

Patterns of paediatric analgesic use in Africa: a systematic review. Arch Dis Child (2012) 1.42

Treatment satisfaction of diabetic patients: what are the contributing factors? Fam Pract (2009) 1.41

Timolol concentrations in breast milk of a woman treated for glaucoma: calculation of neonatal exposure. J Glaucoma (2008) 1.41

Tdap vaccination during pregnancy to reduce pertussis infection in young infants. Can Fam Physician (2013) 1.40

Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov. J Clin Pharmacol (2013) 1.40

Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol (2012) 1.40

Influenza vaccination during pregnancy. Can Fam Physician (2002) 1.39

Electric shock during pregnancy. Can Fam Physician (2003) 1.39

Examining the health and drug exposures among Canadian children residing in drug-producing homes. J Pediatr (2011) 1.39

Terlipressin for children with extremely low cardiac output after open heart surgery. Ann Pharmacother (2009) 1.39

"Cardiac memory": a struggle against forgetting. Circ Res (2003) 1.39

Eating fish during pregnancy. Risk of exposure to toxic levels of methylmercury. Can Fam Physician (2002) 1.37

Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome? J Matern Fetal Neonatal Med (2009) 1.36

Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department. BMJ (2004) 1.35

Gender does matter in perinatal medicine. Fetal Diagn Ther (2004) 1.34

Modulation of celecoxib pharmacokinetics by food in pediatric patients. Clin Pharmacol Ther (2005) 1.33

Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ (2009) 1.32

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol (2005) 1.29

Maternal obesity as an independent risk factor for caesarean delivery. Paediatr Perinat Epidemiol (2004) 1.29

Treatment of nausea and vomiting in pregnancy: an updated algorithm. Can Fam Physician (2007) 1.29

Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neonatal Med (2005) 1.29

Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ (2014) 1.28

The relationship between stress and hair cortisol in healthy pregnant women. Clin Invest Med (2007) 1.26

Systematic evaluation of errors occurring during the preparation of intravenous medication. CMAJ (2008) 1.26

Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol (2002) 1.25

Topical 4% amethocaine gel reduces the pain of subcutaneous measles-mumps-rubella vaccination. Pediatrics (2004) 1.25

Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use. Pharmacogenomics (2008) 1.24

Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol (2010) 1.23

Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf (2004) 1.21